Mobile website
Basic Research
Anti-integrin β1 monoclonal antibody P5D2 inhibits invasion of human cervical squamous carcinoma HCE1 multicellular spheroids into umbilical vein endothelium cells
- Article
- Figures
- Metrics
- Preview PDF
- Reference
- Related
- Cited by
- Materials
Abstract:
Objective:To probe into the relationship between integrin β1 expression in human cervical carcinoma HCE1 multicellular spheroids (HCE1/MCS) and their invasion into human umbilical vein endothelium cells (HUVEC), so as to assess the inhibitory effect of antiintegrin β1 monoclonal antibody P5D2 on the invasion of HCE1/MCS into HUVEC. Methods:A model of HUVEC monolayer invaded by HCE1/MCS was established (in brief, the HCE1 invading model). Morphology changes of the HCE1 invading model were observed under inverted microscope and analyzed by Motic Med System after P5D2 treatment. The expressions of β1 integrin on HCE1 monolayer cells, HCE1/MCS, HVUEC monolayer cells, and P5D2treated HCE1 invading models were measured by immunocytochemistry SABC assay. Results:A HCE1 invading model was successfully established. The HCE1/MCS proliferated rapidly after culture, and on the 7th day the invading area of HCE1/MCS was 40.42 folds larger than the original HCE1/MCS. Invading areas of P5D2treated HCE1/MCS were significantly smaller than that of the control group after 1, 4, 7 day (P<0.05, or P<0.01), with the invading area after 7 days reduced by (84.68±0.08) % compared with the control group. Integrin β1 expression in HCE1/MCS was significantly higher than that in HCE1 monolayer cells (P<0.01), and the expression was negative in HUVEC. Integrin β1 expression in P5D2treated HCE1/MCS was significantly lower than that the in untreated HCE1/MCS (P<0.01). Conclusion:Upregulated expression of integrin β1 in HCE1/MCS and HCE1 invading model may be associated with their enhanced adhesion and invasion abilities. Antiintegrin β1 monoclonal antibody P5D2 can partially block the invasion of HCE1/MCS into HUVEC.
Keywords:
Project Supported:
Project supported by the Science and Technology Development Foundation from Science and Technology Department of Hu′nan Province (No.2007SK3043)
Clc Number:
